Drug Development and the Cost of Failure

by R. Passov This will be one of the most important compounds of our generation. —Jeff Kindler, former CEO, Pfizer, commenting on Torcetrapib Failure of a drug in development, especially in a late stage clinical trial, is shocking. Torcetrapib, for example, failed at the very end of its phase III trial. So many resources had been…